Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Gross Profit: 2009-2025

Historic Gross Profit for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $151.6 million.

  • Prestige Consumer Healthcare's Gross Profit fell 3.69% to $151.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $623.0 million, marking a year-over-year increase of 1.60%. This contributed to the annual value of $634.5 million for FY2025, which is 1.60% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Gross Profit stood at $151.6 million for Q3 2025, which was up 8.02% from $140.3 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Gross Profit registered a high of $170.0 million during Q1 2025, and its lowest value of $137.1 million during Q1 2021.
  • Its 3-year average for Gross Profit is $155.0 million, with a median of $154.7 million in 2023.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Gross Profit climbed by 18.78% in 2021 and then fell by 5.59% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Gross Profit (Quarterly) stood at $155.1 million in 2021, then decreased by 3.00% to $150.4 million in 2022, then grew by 5.01% to $157.9 million in 2023, then rose by 1.97% to $161.0 million in 2024, then fell by 3.69% to $151.6 million in 2025.
  • Its Gross Profit was $151.6 million in Q3 2025, compared to $140.3 million in Q2 2025 and $170.0 million in Q1 2025.